474 related articles for article (PubMed ID: 27665128)
61. Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties.
Zhou QT; Qu L; Gengenbach T; Denman JA; Larson I; Stewart PJ; Morton DA
Int J Pharm; 2011 Jul; 413(1-2):36-43. PubMed ID: 21527321
[TBL] [Abstract][Full Text] [Related]
62. Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating.
Jannin V; Bérard V; N'Diaye A; Andrès C; Pourcelot Y
Int J Pharm; 2003 Aug; 262(1-2):39-45. PubMed ID: 12927386
[TBL] [Abstract][Full Text] [Related]
63. Investigation of the tableting behavior of Ibuprofen DC 85 W.
Al-Karawi C; Cech T; Bang F; Leopold CS
Drug Dev Ind Pharm; 2018 Aug; 44(8):1262-1272. PubMed ID: 29499616
[TBL] [Abstract][Full Text] [Related]
64. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 5: Effects of lubricants and flow conditions.
Asker AF; Saied KM; Abdel-Khalek MM
Pharmazie; 1975 Jun; 30(6):378-82. PubMed ID: 169527
[TBL] [Abstract][Full Text] [Related]
65. Effect of particle properties on the flowability of ibuprofen powders.
Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
[TBL] [Abstract][Full Text] [Related]
66. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials.
Faqih AM; Mehrotra A; Hammond SV; Muzzio FJ
Int J Pharm; 2007 May; 336(2):338-45. PubMed ID: 17289312
[TBL] [Abstract][Full Text] [Related]
67. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
[TBL] [Abstract][Full Text] [Related]
68. Influence of compacted hydrophobic and hydrophilic colloidal silicon dioxide on tableting properties of pharmaceutical excipients.
Jonat S; Hasenzahl S; Gray A; Schmidt PC
Drug Dev Ind Pharm; 2005 Aug; 31(7):687-96. PubMed ID: 16207616
[TBL] [Abstract][Full Text] [Related]
69. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
[TBL] [Abstract][Full Text] [Related]
70. Rapid quantitative analysis of magnesium stearate in pharmaceutical powders and solid dosage forms by atomic absorption: method development and application in product manufacturing.
Sugisawa K; Kaneko T; Sago T; Sato T
J Pharm Biomed Anal; 2009 Apr; 49(3):858-61. PubMed ID: 19195812
[TBL] [Abstract][Full Text] [Related]
71. A drop penetration method to measure powder blend wettability.
Wang Y; Liu Z; Muzzio F; Drazer G; Callegari G
Int J Pharm; 2018 Mar; 538(1-2):112-118. PubMed ID: 29253584
[TBL] [Abstract][Full Text] [Related]
72. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
73. Impact of dry coating lactose as a brittle excipient on multi-component blend processability.
Lin Z; Cabello B; Davé RN
Int J Pharm; 2024 Mar; 653():123921. PubMed ID: 38382769
[TBL] [Abstract][Full Text] [Related]
74. Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch.
Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Leroux JC
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1155-62. PubMed ID: 12237529
[TBL] [Abstract][Full Text] [Related]
75. A novel zein-based dry coating tablet design for zero-order release.
Guo HX; Shi YP
Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
[TBL] [Abstract][Full Text] [Related]
76. Dissolution of a poorly water-soluble drug dry coated with magnesium and sodium stearate.
Tay T; Morton DA; Gengenbach TR; Stewart PJ
Eur J Pharm Biopharm; 2012 Feb; 80(2):443-52. PubMed ID: 22036990
[TBL] [Abstract][Full Text] [Related]
77. Fast dispersible ibuprofen tablets.
Schiermeier S; Schmidt PC
Eur J Pharm Sci; 2002 Apr; 15(3):295-305. PubMed ID: 11923062
[TBL] [Abstract][Full Text] [Related]
78. Applying a novel electrostatic dry powder coating technology to pellets.
Yang Q; Ma Y; Zhu J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
[TBL] [Abstract][Full Text] [Related]
79. Simplified formulations with high drug loads for continuous twin-screw granulation.
Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
[TBL] [Abstract][Full Text] [Related]
80. Upscaling of external lubrication from a compaction simulator to a rotary tablet press.
de Backere C; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2023 Feb; 633():122616. PubMed ID: 36642348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
